Seeing Is Believing
Currently out of the existing stock ratings of John Walsh, 104 are a HOLD (35.37%), 170 are a BUY (57.82%), 20 are a SELL (6.8%).
Analyst John Walsh, carries an average stock price target met ratio of 68.57% that have a potential upside of 27.94% achieved within 327 days. Previously, John Walsh worked at CREDIT SUISSE.
John Walsh’s has documented 623 price targets and ratings displayed on 39 stocks. The coverage was on Industrials, Technology, Basic Materials, Healthcare, Utilities sectors.
Most recent stock forecast was given on PNT, POINT Biopharma Global at 04-Oct-2023.
Analyst best performing recommendations are on GTLS (CHART INDUSTRIES).
The best stock recommendation documented was for GTLS (CHART INDUSTRIES) at 10/13/2020. The price target of $80 was fulfilled within 1 day with a profit of $4.69 (6.23%) receiving and performance score of 62.28.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$185
$7.51 (4.23%)
$163
19 days ago
(30-Sep-2025)
23/31 (74.19%)
$8.27 (4.68%)
278
Buy
$198
$20.51 (11.56%)
$170
1 months 4 days ago
(15-Sep-2025)
7/8 (87.5%)
$20.96 (11.84%)
546
Hold
$175
$-2.49 (-1.40%)
$110
2 months 21 days ago
(28-Jul-2025)
7/7 (100%)
$11.37 (6.95%)
492
Hold
$175
$-2.49 (-1.40%)
$150
2 months 25 days ago
(24-Jul-2025)
18/18 (100%)
$10.09 (6.12%)
370
Hold
$155
$-22.49 (-12.67%)
$145
2 months 25 days ago
(24-Jul-2025)
11/12 (91.67%)
$-9.91 (-6.01%)
385
What Year was the first public recommendation made by John Walsh?